Diabetes

By Jonah Comstock December 14, 2015
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence. The two companies partnered in June on diabetes around the same time Medtronic received FDA clearance for its MiniMed Connect device that connects Medtronic CGMs...
By Jonah Comstock November 11, 2015
When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough. "I remember, trying to make sense of all of this, the doctor saying 'In three years, we’ll have perfected the artificial pancreas and you won’t have to worry about this'," Stack recalled at a panel discussion at the...
By Jonah Comstock September 30, 2015
Voluntis's Diabeo app, not available in the United States French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer. Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
By Jonah Comstock September 23, 2015
Glooko and Joslin's HypoMap Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.gov posting. The web platform will help educate patients about how to optimize their glucose and analyze their after-meal behavior. The app will facilitate data logging to help...
By Jonah Comstock September 16, 2015
An Oscar-branded Misfit Flash device. Oscar, a small New York City-based health insurer noted for its individual focus and digital health savvy, has secured a $32.5 million investment from Google Capital, one of the search giant's two investment arms. The investment may well be strategic, according to the Wall Street Journal, which broke the story. Last April, Oscar raised $145 million in a...
By Jonah Comstock September 8, 2015
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients. Patent applications don't always presage exactly...
By Jonah Comstock July 14, 2015
Welkin Health, a San Francisco-based population health management company that provides a combination of mobile, web, and telephone-based coaching programs, has raised $2 million in seed funding and announced its first major pilot, which is with Humana's Innovation Group. Investors in the seed round include Rock Health, Asset Management Ventures, Great Oaks VC, iSeed VC, a direct investment from...
By Jonah Comstock June 4, 2015
New York City and Austin, Texas-based Informed Data Systems has raised $8 million for its One Drop mobile diabetes management platform. The round was led by RRE, with additional contributions from BoxGroup, Capital Factory, and existing investors LAUNCH fund and Neu Ventures. One Drop is a direct-to-consumer app for diabetes management, currently available on iOS and Apple Watch. It allows users...
By Jonah Comstock June 3, 2015
The Dexcom Follow Android App Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System. The company announced in March that it would begin to incorporate pumps and CGMs into its system, including those from Medtronic, an investor in Glooko's latest $16.5...
By Jonah Comstock June 3, 2015
Medtronic's Guardian Mobile CGM app, yet to be released in the US. Despite speculations to the contrary from analysts last year, it looks like Medtronic will continue to acquire early-stage health companies even after its Covidien acquisition. On a fourth quarter earnings call, Medtronic CEO Omar Ishrak told analysts that the company would use new cash from the Covidien deal to invest in early...